Skip to content
FIND A HEALTH VALLEY ACTOR

CSEM: 40 years of innovation

CSEM - 40th Birthday

The Swiss Centre for Electronics and Microtechnology (CSEM) celebrates its 40th anniversary in 2024, marking four decades of innovation in key areas such as microtechnology, digitalisation, sustainability and life sciences.     Founded in 1984 in Neuchâtel, the CSEM has become a benchmark in Switzerland and internationally for its expertise in cutting-edge technologies, including renewable…

Read More

Bracco invests EUR 80 Million in Geneva

Bracco

Over 80 million euros have been invested to build Hexagon, a new multi-functional building located next to the historical 1997 plant in Plan-les-Ouates (Geneva – Switzerland).     On 6 November 2024, Bracco inaugurated a new 4-story building characterized by contemporary design and constructed according to the most rigorous sustainability standards in Geneva, which will,…

Read More

Egg or Chicken, who was the first?

Egg or Chicken

Researchers have studied a single-celled organism discovered in Hawaii in 2017. The results have shed some light on this question.     Who was the first? The egg or the chicken? Scientists at the University of Geneva (UNIGE) believe they have found the answer to this age-old question. They think it was the egg. The…

Read More

EPFL Innogrants: 4 life sciences projects awarded

EPFL Innogrants

EPFL’s Startup Launchpad has awarded CHF 100,000 Innogrants to start-up projects based at EPFL: Myriad Optics, Protonica, Dexterous Catheters and Biomatics.     Myriad Optics Myriad Optics is ensuring food safety from farm to fork, thanks to the quick and accurate detection and identification of bacterial pathogens in the food industry. Food contamination can have…

Read More

Lonza to Expand Bioconjugation in Visp with Two Additional Manufacturing Suites

Lonza

Fantastic news for the Swiss Health Valley! After announcing the creation of 100 new jobs in October, Lonza announces the increase of its bioconjugation capabilities with two additional manufacturing sites in Visp (Valais). 200 other new jobs will be created.     Lonza, a global development and manufacturing partner to the pharmaceutical, biotech and nutraceutical…

Read More

HepaVue Awarded By FIT

HepaVue

HepaVue created the world’s first virtual reality liver biopsy to diagnose liver disease. The CHF 100,000 Tech Seed loan granted by the Foundation pour l’Innovation Technologique (FIT) will enable the start-up to finalise its artificial intelligence software and begin production of its radiotracers.     Worldwide, more than 2 billion people are affected by chronic,…

Read More

Atinary Technologies: a new lab in the U.S. and a partnership with Takeda

Atinary team

The Swiss Health Valley company launches its self-driving Data factory: the AI-driven Laboratory for High-Quality Data and Molecules Generation in collaboration with Takeda Pharmaceuticals.     Atinary Technologies, in partnership with Takeda Pharmaceuticals, the largest pharmaceutical company in Japan, has launched a state-of-the-art AI-driven facility in Kendall Square, Cambridge, Massachusetts. Known as the Self-driving Laboratory™, this…

Read More

Xemperia wins the IFF Start-Up Award

Xemperia

The Innovation Fribourg Freiburg (IFF) 2024-2025 Prizes were awarded on 6 November 2024. Xemperia, a University of Fribourg spin-off won the Start-Up Award worth CHF 30’000.     Xemperia won the highest number of votes in a selection process that combined the choices of the jury (one-third) and the public (two-thirds). Since the announcement of…

Read More

The Advanced Science Building:A New Impetus for Basic Research at EPFL

Advanced Science Building

EPFL is investing CHF 200 million in an innovative building specially designed to meet the extreme demands of cutting-edge deep tech research, in the fields of quantum physics, nanotechnology, biology, chemistry and materials. In fields where measurements must be perfectly isolated from outside noise, the challenge is to create an environment that is free from…

Read More

Impli partners with Bayer

Impli x Bayer

Bayer announced a partnership with Impli, a Biopôle-based innovative, femtech start-up in precision care. Impli’s goal is to advance women’s health and deliver the first real-time hormone monitoring device – making fertility more accessible, safer and more successful.     With hormones playing a critical role in many of our body’s systems and functions, real-time…

Read More